Key finding: iSpecimen Inc. (ISPC) is a micro-cap biospecimen marketplace operator that has experienced extreme stock volatility, massive dilution, and a 1-for-40 reverse split in 2026 amid ongoing financial challenges and Nasdaq compliance issues.
iSpecimen Inc. operates a proprietary online marketplace platform that connects life science researchers needing human biospecimens (biofluids, solid tissues, hematopoietic stem and immune cells) with hospitals, laboratories, and other providers. The company serves regions including the Americas, Europe, the Middle East, Africa, and Asia Pacific, with most revenue from the Americas. It was incorporated in 2009, is headquartered in Woburn, Massachusetts, and has approximately 7 full-time employees. Website: ispecimen.com. Investor site: investors.ispecimen.com.
Interpretation: Frequent capital raises and corporate actions (splits, compliance issues) suggest ongoing liquidity challenges typical of micro-cap biotech/tech firms, though operational milestones in AI and logistics indicate efforts to improve the core marketplace.
As of early July 2026 (data around July 8-9, 2026), ISPC traded near $2.29-$2.57 with a market cap of approximately $3.5M. Highly volatile with low average volume relative to spikes.
| Metric | Value | Notes |
|---|---|---|
| 52-Week High | $127.20 | Pre- or post-split adjusted context needed |
| 52-Week Low | $2.26 - $2.39 | Recent lows near July 2026 |
| Recent Close | ~$2.29 - $2.57 | July 2026 trading range |
| 1-Year Return | ~-93% to -94% | Significant underperformance |
| Market Cap | ~$3.4M - $3.8M | Micro-cap |
| Shares Outstanding | ~1.52M | Post-split / post-offerings |
| TTM Revenue | ~$1.0M - $1.9M | Low revenue base |
| All-Time High | Extremely high (e.g., reported ~$16k pre-adjustments in 2021) | Extreme historical volatility |
Interpretation: The stock has undergone dramatic declines and dilution events, with reverse split and offerings likely resetting prices but not resolving underlying fundamentals. Limitation/Assumption: Exact pre-split historical prices and precise share counts vary by source due to multiple corporate actions; always verify with primary filings.
Facts: All company description, founding date, IPO date, recent news dates/events, and price ranges are directly from search results (e.g., Yahoo Finance, company releases via TipRanks/GlobeNewswire/Newsfile).
Interpretations: Comments on financial challenges or strategy are analyst-style inferences based on patterns in news (dilution, compliance notices); not definitive predictions.
Uncertainties & Data Limitations: Stock data is time-sensitive and reflects ~July 2026 crawls; prices fluctuate rapidly. Historical highs/lows may require adjustment for splits. Financials (revenue/losses) are approximate TTM figures. No forward-looking advice; past performance is not indicative of future results. Crypto plans appear exploratory and not core. Verify all with SEC filings and real-time quotes. Data sourced exclusively from provided web search results.